[Treatment with vitamin D, D hormones and synthetic analogs].
Kruse
H P
HP
D002117:Calcitriol / Q000627:therapeutic use; D053493:Cholestanetriol 26-Monooxygenase; D004789:Enzyme Activation; D006801:Humans; D006996:Hypocalcemia / Q000188:drug therapy*; D007668:Kidney / Q000378:metabolism; D010018:Osteomalacia / Q000188:drug therapy*; D018167:Receptors, Calcitriol; D011987:Receptors, Steroid / Q000378:metabolism; D013250:Steroid Hydroxylases / Q000378:metabolism; D014807:Vitamin D / Q000031:analogs & derivatives / Q000627:therapeutic use*; D014808:Vitamin D Deficiency / Q000188:drug therapy
D018167:Receptors, Calcitriol; D011987:Receptors, Steroid; D014807:Vitamin D; D013250:Steroid Hydroxylases; C506831:CYP27A1 protein, human; D053493:Cholestanetriol 26-Monooxygenase; D002117:Calcitriol
Behandlung mit Vitamin D, D-Hormonen und synthetischen Analogen.